TAKARA BIO INC.JP:4974

Market cap
¥94.8B
P/E ratio
-10.5x
2014/032015/032016/032017/032018/032019/032020/032021/032022/032023/032024/032025/03
Cash and cash equivalents -20,58419,38428,07817,53717,03318,26625,99323,63351,84735,41629,549
Marketable securities, current -3,2999,7212,0002,0002,0002,000-----
Accounts receivable, net-6,7416,8307,4558,0318,6049,10212,626----
Inventories-3,5603,8224,0324,4844,5234,5114,96618,9666,2486,7846,794
Total current assets-36,44742,15843,96435,03235,27538,38749,11568,14177,56962,75957,679
Property, plant and equipment, net-20,53220,53419,57718,53421,40424,21329,76636,39540,95649,07556,954
Total non-current assets-29,97824,43223,17833,82135,76536,62240,63547,57151,63258,49267,655
Total assets -66,42566,59167,14368,85471,04075,00989,750115,712129,202121,252125,334
Accounts payable-1,9391,6901,9441,8751,5361,0272,0771,9592,3231,5431,652
Short-term debt-576347--------
Total current liabilities-5,4395,4306,0255,7456,0176,24813,19117,38014,3757,1687,131
Long-term debt, non-current -17813082--------
Total non-current liabilities-1,3431,0501,1311,1499272,1692,2562,2662,3722,2992,353
Total liabilities -6,7836,4807,1576,8946,9458,41815,44819,64716,7479,4679,485
Common stock and paid-in capital -47,85847,85847,85847,85847,85847,85847,85847,85847,85847,85847,858
Retained earnings-8,1429,29510,43212,28515,40118,50127,08545,00957,04753,47152,465
Stockholders' equity57,12759,64260,11059,98561,95964,09566,59174,30296,064112,454111,784115,849